期刊
WORLD JOURNAL OF GASTROENTEROLOGY
卷 20, 期 25, 页码 8092-8101出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v20.i25.8092
关键词
Metabolomics; Gastric cancer; Chemosensitivity; Metastasis; Biomarkers; Nuclear magnetic resonance spectroscopy; Liquid/gas chromatography and mass spectrometry
资金
- Research Council of Norway [70174300]
Metabolomics is a field of study in systems biology that involves the identification and quantification of metabolites present in a biological system. Analyzing metabolic differences between unperturbed and perturbed networks, such as cancerous and non-cancerous samples, can provide insight into underlying disease pathology, disease prognosis and diagnosis. Despite the large number of review articles concerning metabolomics and its application in cancer research, biomarker and drug discovery, these reviews do not focus on a specific type of cancer. Metabolomics may provide biomarkers useful for identification of early stage gastric cancer, potentially addressing an important clinical need. Here, we present a short review on metabolomics as a tool for biomarker discovery in human gastric cancer, with a primary focus on its use as a predictor of anticancer drug chemosensitivity, diagnosis, prognosis, and metastasis. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据